Voloridge Investment Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.2M | Buy |
749,788
+165,219
| +28% | +$2.03M | 0.03% | 570 |
|
2025
Q1 | $12.9M | Sell |
584,569
-144,847
| -20% | -$3.19M | 0.05% | 488 |
|
2024
Q4 | $16.5M | Sell |
729,416
-329,710
| -31% | -$7.48M | 0.06% | 409 |
|
2024
Q3 | $19.2M | Buy |
1,059,126
+231,270
| +28% | +$4.2M | 0.07% | 385 |
|
2024
Q2 | $24.1M | Buy |
827,856
+256,536
| +45% | +$7.48M | 0.09% | 309 |
|
2024
Q1 | $20.3M | Buy |
571,320
+260,992
| +84% | +$9.25M | 0.07% | 332 |
|
2023
Q4 | $13.5M | Buy |
310,328
+33,935
| +12% | +$1.48M | 0.05% | 403 |
|
2023
Q3 | $10.6M | Buy |
276,393
+8,488
| +3% | +$324K | 0.05% | 453 |
|
2023
Q2 | $11M | Buy |
267,905
+168,751
| +170% | +$6.94M | 0.05% | 435 |
|
2023
Q1 | $5.69M | Sell |
99,154
-53,835
| -35% | -$3.09M | 0.03% | 634 |
|
2022
Q4 | $8.58M | Sell |
152,989
-66,807
| -30% | -$3.75M | 0.05% | 472 |
|
2022
Q3 | $9.31M | Buy |
219,796
+86,663
| +65% | +$3.67M | 0.05% | 462 |
|
2022
Q2 | $7.19M | Buy |
133,133
+42,045
| +46% | +$2.27M | 0.04% | 549 |
|
2022
Q1 | $5.85M | Buy |
+91,088
| New | +$5.85M | 0.03% | 588 |
|
2021
Q2 | – | Sell |
-3,677
| Closed | -$254K | – | 1684 |
|
2021
Q1 | $254K | Sell |
3,677
-81,981
| -96% | -$5.66M | ﹤0.01% | 1278 |
|
2020
Q4 | $5.56M | Sell |
85,658
-39,201
| -31% | -$2.54M | 0.05% | 427 |
|
2020
Q3 | $5.9M | Buy |
124,859
+105,714
| +552% | +$4.99M | 0.05% | 405 |
|
2020
Q2 | $900K | Sell |
19,145
-15,429
| -45% | -$725K | 0.01% | 887 |
|
2020
Q1 | $1.54M | Sell |
34,574
-3,913
| -10% | -$175K | 0.04% | 416 |
|
2019
Q4 | $2.24M | Buy |
+38,487
| New | +$2.24M | 0.04% | 466 |
|